<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) <break/>or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td valign="top">Gene (Homo sapiens)</td><td valign="top">CD95L</td><td valign="top">NA</td><td valign="top">NM_000639</td><td valign="top"/></tr><tr><td valign="top">Gene (H. sapiens)</td><td valign="top">CD95</td><td valign="top">NA</td><td valign="top">NM_000043</td><td valign="top"/></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">MCF-7</td><td valign="top">ATCC</td><td valign="top">ATCC: HTB-22</td><td valign="top">Human adenocarcinoma of the mammary <break/>gland, breast; derived from metastatic site: <break/>pleural effusion</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">MCF-7 CD95 <break/>&#916;shR6 clone <break/>#21</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">MCF-7 CD95 &#916;shR6 clone #21 with homozygous <break/>227 nucleotide deletion of the shR6 target <break/>site in CD95 (chr10:89,008,920&#8211;89,009,146; <break/>Human Dec. 2013 GRCh38/hg38 assembly) <break/>produced using CRISPR/Cas9 technology; <break/>verified homozygous CD95 protein knockout</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">MCF-7 CD95 <break/>deletion <break/>clone FA4</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">MCF-7 CD95 deletion clone FA4 with a <break/>homozygous deletion of the entire <break/>CD95 gene (chr10:88,990,657&#8211;89,015,785; <break/>Human Dec. 2013 GRCh38/hg38 assembly) <break/>produced using CRISPR/Cas9 technology; <break/>verified homozygous CD95 protein knockout</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">HeyA8</td><td valign="top">PMID: 4016745</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_8878">CVCL_8878</ext-link></td><td valign="top">Human high grade ovarian serous <break/>adenocarcinoma; derived from parent <break/>Hey cells (RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0297">CVCL_0297</ext-link>)</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">HeyA8 shR6 k.o. <break/>clone #11, HeyA8 <break/>CD95 k.o.</td><td valign="top">PMID: 29063830</td><td valign="top">NA</td><td valign="top">HeyA8 CD95 k.o. clone with a homozygous <break/>227 nucleotide deletion of the shR6 target <break/>site in CD95 (chr10:89,008,920&#8211;89,009,146; <break/>Human Dec. 2013 GRCh38/hg38 assembly) <break/>produced using CRISPR/Cas9 technology; <break/>verified homozygous CD95 protein knockout</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">HCT116</td><td valign="top">Korean Collection <break/>for Type Cultures <break/>(KCTC)</td><td valign="top">KCTC: cat#HC19023; <break/>ATCC: CCL_247</td><td valign="top">Human colorectal carcinoma</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">Drosha<sup>-/-</sup>; <break/>Drosha<sup>-/-</sup> <break/>clone #40</td><td valign="top">Korean Collection for <break/>Type Cultures (KCTC); <break/>PMID: 26976605</td><td valign="top">KCTC: cat#HC19020</td><td valign="top">HCT116 clone #40 with homozygous <break/>knockout of Drosha&#160;protein; knockout <break/>achieved using CRISPR/Cas9 which resulted <break/>in a single nucleotide insertion in one allele and <break/>a 26 nucleotide deletion in the other</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">Dicer<sup>-/-</sup>; <break/>Dicer<sup>-/-</sup> <break/>clone #43</td><td valign="top">Korean Collection for <break/>Type Cultures (KCTC); <break/>PMID: 26976606</td><td valign="top">KCTC: cat#HC19023</td><td valign="top">HCT116 clone #43 with homozygous <break/>knockout of Dicer&#160;protein; knockout <break/>achieved using CRISPR/Cas9 which resulted <break/>in a three nucleotide insertion and 14 <break/>nucleotide deletion in one allele and a <break/>35 nucleotide deletion in the other</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">Dicer<sup>-/-</sup>; <break/>Dicer<sup>-/-</sup> clone #45</td><td valign="top">Korean Collection for <break/>Type Cultures (KCTC); <break/>PMID: 26976607</td><td valign="top">KCTC: cat#HC19024</td><td valign="top">HCT116 clone #45 with homozygous <break/>knockout of Dicer&#160;protein; knockout achieved using <break/>CRISPR/Cas9 which resulted in a 53 nucleotide <break/>deletion in one allele and a 28 nucleotide <break/>deletion in the other</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">293T</td><td valign="top">ATCC</td><td valign="top">ATCC: CRL-3216</td><td valign="top">Derived from HEK293 cells (ATCC: CRL-1573); <break/>express large T antigen; used for <break/>packaging viruses</td></tr><tr><td valign="top">Cell line (H. sapiens)</td><td valign="top">H460</td><td valign="top">ATCC</td><td valign="top">ATCC: #HTB-177</td><td valign="top">Human lung pleural effusion carcinoma</td></tr><tr><td valign="top">Cell line (Mus musculus)</td><td valign="top">3LL</td><td valign="top">ATCC</td><td valign="top">ATCC #CRL-1642</td><td valign="top">Mouse Lewis lung carcinoma</td></tr><tr><td valign="top">Cell line (Mus musculus)</td><td valign="top">M565</td><td valign="top">PMID: 25366259</td><td valign="top">NA</td><td valign="top">Mouse hepatocellular carcinoma <break/>isolated from naturally occurring tumor <break/>in a floxed CD95 background</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human AGO1 <break/>(rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">Cell Signaling #5053</td><td valign="top">1:2000; for western blot; primary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human AGO1 <break/>(rabbit polyclonal)</td><td valign="top">Abcam</td><td valign="top">Abcam #98056</td><td valign="top">1:2000; for western blot; primary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human AGO2 <break/>(rabbit polyclonal)</td><td valign="top">Abcam</td><td valign="top">Abcam #32381</td><td valign="top">1:500; for western blot; primary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat anti-rabbit, <break/>IgG-HRP</td><td valign="top">Southern Biotech</td><td valign="top">Southern Biotech: <break/>cat#SB-4030&#8211;05</td><td valign="top">1:5000; for western blot; secondary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Argonaute-2 <break/>antibody (rabbit <break/>monoclonal) <break/>[EPR10411]</td><td valign="top">Abcam</td><td valign="top">Abcam #186733</td><td valign="top">1:1200; for western blot; primary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Human CD178 <break/>antibody (Mouse IgG1) <break/>Clone G247-4</td><td valign="top">BD Pharmingen</td><td valign="top">BD Pharmingen <break/>#556387</td><td valign="top">1 &#956;g/ml; for western blot; primary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-CD95 (rabbit <break/>polyclonal, C-20)</td><td valign="top">Santa Cruz</td><td valign="top">Santa Cruz #sc-715 <break/>(since discontinued)</td><td valign="top">1:1000; for western blot; primary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat anti-rabbit, <break/>IgG-HRP</td><td valign="top">Cell Signaling</td><td valign="top">Cell Signaling: cat#7074</td><td valign="top">1:2000; for western blot; secondary Ab</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat anti-mouse; <break/>IgG1-HRP</td><td valign="top">Southern Biotech</td><td valign="top">Southern BioTech: <break/>cat#1070&#8211;05</td><td valign="top">1:5000; for western blot; secondary Ab</td></tr><tr><td valign="top">Recombinant <break/>protein reagent</td><td valign="top">LzCD95L</td><td valign="top">PMID: 14504390</td><td valign="top">NA</td><td valign="top">Leucine zipper tagged CD95L; <break/>recombinant protein</td></tr><tr><td valign="top">Chemical compound</td><td valign="top">CellTiter-Glo</td><td valign="top">Promega</td><td valign="top">Promega #G7570</td><td valign="top">Detects ATP release as a surrogate <break/>for cell death; read-out is fluorescence</td></tr><tr><td valign="top">Chemical compound</td><td valign="top">propidium iodide</td><td valign="top">Sigma-Aldrich</td><td valign="top">Sigma-Aldrich: <break/>cat#P4864</td><td valign="top">Used for subG1 flow cytometry analysis</td></tr><tr><td valign="top">Chemical compound</td><td valign="top">puromycin</td><td valign="top">Sigma-Aldrich</td><td valign="top">Sigma-Aldrich: <break/>cat#P9620</td><td valign="top">Used for selection of cells expressing <break/>puromycin resistance cassettes</td></tr><tr><td valign="top">Chemical compound</td><td valign="top">2',7'-dichlorodihydrofluorescein&#160;diacetate</td><td valign="top">Thermofisher Scientific</td><td valign="top">Thermofisher <break/>Scientific #D399</td><td valign="top">Dye used for detecting ROS production</td></tr><tr><td valign="top">Chemical compound</td><td valign="top">zVAD-fmk</td><td valign="top">Sigma-Aldrich</td><td valign="top">Sigma-Aldrich: <break/>cat#V116</td><td valign="top">Used at 20 uM; pan caspase inhibitor</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pLenti-GIII-CMV- <break/>RFP-2A-Puro <break/>vector; pLenti</td><td valign="top">ABM Inc</td><td valign="top">NA</td><td valign="top">pLenti control empty lentiviral vector; <break/>carries an RFP-2a-puromycin <break/>resistance cassette</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pLenti-CD95L</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">pLenti-GIII-CMV-RFP-2A-Puro vector that <break/>expresses human wild type CD95L cDNA <break/>(NM_000639.2); used to express wt human <break/>CD95L upon infection with lentiviral particles</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pLenti-CD95L<sup>MUT</sup></td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">pLenti-GIII-CMV-RFP-2A-Puro vector that <break/>expresses human CD95L cDNA <break/>(NM_000639.2) with two nucleotide <break/>substitutions in codon 218 (TAT -&#160;&gt;&#160;CGT) <break/>resulting in replacement of tyrosine <break/>for arginine (Y218R mutation); <break/>unable to bind CD95</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pLenti-CD95L<sup>MUT</sup>NP</td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">pLenti-GIII-CMV-RFP-2A-Puro vector that <break/>expresses human CD95L cDNA (NM_000639.2) <break/>with both the Y218R mutation and a <break/>single nucleotide substitution at the <break/>second codon (CAG -&#160;&gt;&#160;TAG), resulting in a <break/>premature stop codon right <break/>after the start codon</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pLenti-CD95L<sup>SIL</sup></td><td valign="top">this paper</td><td valign="top">NA</td><td valign="top">pLenti-GIII-CMV-RFP-2A-Puro vector that <break/>expresses human CD95L cDNA (NM_000639.2) <break/>with all codons containing synonymous <break/>mutations except for select codons in the <break/>proline-rich domain to meet <break/>IDT synthesis criteria</td></tr><tr><td valign="top">Transfected <break/>construct</td><td valign="top">gRNA scaffold</td><td valign="top">PMID: 23287722</td><td valign="top">IDT: synthesized <break/>as gene block</td><td valign="top">455 nucleotide CRISPR/Cas9 gRNA scaffold <break/>synthesized as a gene block; contains <break/>promoter, gRNA scaffold, target sequence, <break/>and termination sequence; scaffold <break/>transcribes gRNAs that target Cas9 <break/>endonuclease to cut at target sites; <break/>target sequences consist of 19 nucleotides <break/>that are complementary to the target <break/>site of choice; co-transfected with <break/>Cas9 to catalyze cleavage.</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pLenti-CD95L<sup>MUT</sup>NP <break/>(G258A)</td><td valign="top">This paper</td><td valign="top">NA</td><td valign="top">pLenti-GIII-CMV-RFP-2A-Puro vector that <break/>expresses human CD95L cDNA <break/>(NM_000639.2) with the Y218R mutation, <break/>and two additional single nucleotide <break/>substitutions; one at the second codon <break/>(CAG -&#160;&gt;&#160;TAG), resulting in a premature stop <break/>codon right after the start codon, and <break/>another, G258A, resulting in the replacement <break/>of a methionine with an isoleucine, thus <break/>removing the alternative <break/>translational start site.</td></tr><tr><td valign="top">Transfected <break/>construct</td><td valign="top">pMJ920 Cas9 plasmid</td><td valign="top">Addgene; <break/>PMID: 23386978</td><td valign="top">Addgene: cat#42234</td><td valign="top">Plasmid that expresses a human <break/>codon-optimized Cas9 tagged with <break/>GFP and HA; used to express Cas9 for <break/>CRISPR-mediated deletions.</td></tr><tr><td valign="top">Chemical <break/>compound</td><td valign="top">Lipofectamine 2000</td><td valign="top">ThermoFisher Scientific</td><td valign="top">ThermoFisher <break/>Scientific: <break/>cat#11668019</td><td valign="top">Transfection reagent</td></tr><tr><td valign="top">Chemical <break/>compound</td><td valign="top">Lipofectamine RNAiMAX</td><td valign="top">ThermoFisher Scientific</td><td valign="top">ThermoFisher <break/>Scientific: <break/>cat#13778150</td><td valign="top">Transfection reagent; used for <break/>transfection of small <break/>RNAs such as siRNAs</td></tr><tr><td valign="top">Commercial <break/>assay or kit</td><td valign="top">StrataClone Blunt <break/>PCR Cloning Kit</td><td valign="top">Agilent Technologies</td><td valign="top">Agilent <break/>Technologies: <break/>cat#240207</td><td valign="top">Used to blunt-end clone the gRNA <break/>scaffolds into the pSC-B plasmid</td></tr><tr><td valign="top">Genetic reagent</td><td valign="top">Taqman Gene <break/>expression master mix</td><td valign="top">ThermoFisher Scientific</td><td valign="top">#4369016</td><td valign="top"/></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">shR6 flanking Fr primer</td><td valign="top">IDT</td><td valign="top">IDT: custom <break/>DNA oligo</td><td valign="top">Fr primer that flanks shR6 site; <break/>used to detect 227 nt shR6 deletion; <break/>5&#8217;-GGTGTCATGCTGTGACTGTTG-3&#8217;</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">shR6 flanking Rev primer</td><td valign="top">IDT</td><td valign="top">IDT: custom <break/>DNA oligo</td><td valign="top">Rev primer that flanks shR6 site; <break/>used to detect 227 nt shR6 deletion; <break/>5&#8217;-TTTAGCTTAAGTGGCCAGCAA-3&#8217;</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">shR6 internal Rev primer</td><td valign="top">IDT</td><td valign="top">IDT: custom <break/>DNA oligo</td><td valign="top">Rev primer that overlaps <break/>with the shR6 site; <break/>used to detect 227 nt shR6 deletion; <break/>5&#8217;-AAGTTGGTTTACATCTGCAC-3&#8217;</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">CD95 flanking Fr primer</td><td valign="top">IDT</td><td valign="top">IDT: custom <break/>DNA oligo</td><td valign="top">Fr primer that flanks the CD95 gene; <break/>used to detect CD95 gene deletion; <break/>5&#8217;-TGTTTAATATAGCTGGGGCTATGC-3'</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">CD95 flanking Rev primer</td><td valign="top">IDT</td><td valign="top">IDT: custom <break/>DNA oligo</td><td valign="top">Rev primer that flanks the CD95 gene; <break/>used to detect CD95 gene deletion; <break/>5&#8217;-TGGGACTCATGGGTTAAATAGAAT-3&#8217;</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">CD95 internal Rev primer</td><td valign="top">IDT</td><td valign="top">IDT: custom <break/>DNA oligo</td><td valign="top">Rev internal primer that targets within <break/>the CD95 gene; used to detect CD95 <break/>gene deletion; <break/>5&#8217;-GACCAGTCTTCTCATTTCAGAGGT-3&#8217;</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">siScr/siNT1</td><td valign="top">IDT;</td><td valign="top">IDT: custom <break/>DNA oligo</td><td valign="top">control non-targeting siRNA; <break/>sense: UGGUUUACAUGUCGACUAA-3'</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">c7/1</td><td valign="top">IDT</td><td valign="top">custom siRNA; <break/>antisense strand <break/>corresponds to <break/>cluster 7 CD95L <break/>sequence</td><td valign="top">antisense: 5&#8217;-AUUGGGCCUG <break/>GGGAUGUUU-3'; <break/>antisense strand designed with 3' <break/>deoxy AA; complementary sense strand <break/>has 3' deoxy TT and 2'-O-methylation at <break/>the first two positions</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">c7/2</td><td valign="top">IDT</td><td valign="top">custom siRNA; <break/>antisense strand <break/>corresponds to <break/>cluster 7 CD95L <break/>sequence</td><td valign="top">antisense: 5&#8217;-CCUGGGGAU <break/>GUUUCAGCUC-3&#8217;; <break/>antisense strand designed with 3' <break/>deoxy AA; complementary sense strand <break/>has 3' deoxy TT and 2'-O-methylation at the <break/>first two positions</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">c11</td><td valign="top">IDT</td><td valign="top">custom siRNA; <break/>antisense strand <break/>corresponds to <break/>cluster 11 CD95L <break/>sequence</td><td valign="top">antisense: 5&#8217;-CCAACUCAAGG <break/>UCCAUGCC-3&#8217;; <break/>antisense strand designed with 3' <break/>deoxy AA; complementary sense strand <break/>has 3' deoxy TT and 2'-O-methylation at the <break/>first two positions</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">c15/1</td><td valign="top">IDT</td><td valign="top">custom siRNA; <break/>antisense strand <break/>corresponds to <break/>cluster 15 CD95L <break/>sequence</td><td valign="top">antisense: 5&#8217;-AAACUGGGCUGU <break/>ACUUUGU-3&#8217;; <break/>antisense strand designed with 3' <break/>deoxy AA; complementary sense strand <break/>has 3' deoxy TT and 2'-O-methylation at <break/>the first two positions</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">c15/2</td><td valign="top">IDT</td><td valign="top">custom siRNA; <break/>antisense strand <break/>corresponds to <break/>cluster 15 CD95L <break/>sequence</td><td valign="top">antisense: 5&#8217;- AACUGGGCUGU <break/>ACUUUGUA-3&#8217;; <break/>antisense strand designed with 3' <break/>deoxy AA; complementary sense strand <break/>has 3' deoxy TT and 2'-O-methylation at the <break/>first two positions</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">c16/1</td><td valign="top">IDT</td><td valign="top">custom siRNA; <break/>antisense strand <break/>corresponds to <break/>cluster 16 CD95L <break/>sequence</td><td valign="top">antisense: 5&#8217;- CAACAACCUGCC <break/>CCUGAGC-3&#8217;; <break/>antisense strand designed with 3' <break/>deoxy AA; complementary sense strand <break/>has 3' deoxy TT and 2'-O-methylation at the <break/>first two positions</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">c16/2</td><td valign="top">IDT</td><td valign="top">custom siRNA; <break/>antisense strand <break/>corresponds to <break/>cluster 16 CD95L <break/>sequence</td><td valign="top">antisense: 5&#8217;- AACUCUAAGCG <break/>UCCCCAGG-3&#8217;; <break/>antisense strand designed with 3' <break/>deoxy AA; complementary sense strand <break/>has 3' deoxy TT and 2'-O-methylation at <break/>the first two positions</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">c21</td><td valign="top">IDT</td><td valign="top">custom siRNA; <break/>antisense strand <break/>corresponds to <break/>cluster 21 CD95L <break/>sequence</td><td valign="top">antisense: 5&#8217;- UCAACGUAUC <break/>UGAGCUCUC-3&#8217;; <break/>antisense strand designed with 3' <break/>deoxy AA; complementary sense strand <break/>has 3' deoxy TT and 2'-O-methylation at the <break/>first two positions</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">c22</td><td valign="top">IDT</td><td valign="top">custom siRNA; <break/>antisense strand <break/>corresponds to <break/>cluster 22 CD95L <break/>sequence</td><td valign="top">antisense: 5&#8217;- AAUCUCAGACG <break/>UUUUUCGG-3&#8217;; <break/>antisense strand designed with 3' <break/>deoxy AA; complementary sense strand <break/>has 3' deoxy TT and 2'-O-methylation at <break/>the first two positions</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">siCtr pool</td><td valign="top">Dharmacon</td><td valign="top">D-001810&#8211;10</td><td valign="top">control non-targeting siRNA pool</td></tr><tr><td valign="top">Sequence-based <break/>reagent</td><td valign="top">SMARTpool siRNA <break/>targeting AGO2</td><td valign="top">Dharmacon</td><td valign="top">L-004639-00-0005</td><td valign="top">siRNA pool designed to target AGO2</td></tr><tr><td valign="top">Sequence based <break/>reagent (human)</td><td valign="top">GAPDH primer</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00266705_g1</td><td valign="top">RT-qPCR; control probe</td></tr><tr><td valign="top">Sequence based <break/>reagent (human)</td><td valign="top">CD95L primers</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00181226_g1; <break/>Hs00181225_m1</td><td valign="top">RT-qPCR</td></tr><tr><td valign="top">Sequence based <break/>reagent (human)</td><td valign="top">CD95 primers</td><td valign="top">Thermofisher Scientific</td><td valign="top">Hs00531110_m1; <break/>Hs00236330_m1</td><td valign="top">RT-qPCR</td></tr><tr><td valign="top">Sequence based <break/>reagent (human)</td><td valign="top">CD95L<sup>SIL</sup> primer</td><td valign="top">Thermofisher Scientific</td><td valign="top">assay ID: <break/>APNKTUD</td><td valign="top">Custom RT-qPCR primer designed <break/>using the Thermofisher Scientific <break/>design tool to detect CD95L<sup>SIL</sup> mRNA</td></tr><tr><td valign="top">Sequence based <break/>reagent (human)</td><td valign="top">Cluster 8 CD95L <break/>small RNA primer</td><td valign="top">Thermofisher Scientific</td><td valign="top">custom probe <break/>Assay ID: <break/>CT7DPEM</td><td valign="top">Custom RT-qPCR primer designed using <break/>the Thermofisher Scientific design tool at <break/><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/order/custom-">https://www.thermofisher.com/order/custom-</ext-link> <break/>genomic-products/tools/small-rna to <break/>specifically detect small RNAs from <break/>cluster 8 of CD95L <break/>(5&#8217;- AAGGAGCTGGCAGAACTCCGAGA-3&#8217;)</td></tr><tr><td valign="top">Sequence based <break/>reagent (human)</td><td valign="top">Cluster 21 CD95L <break/>small RNA primer</td><td valign="top">Thermofisher Scientific</td><td valign="top">custom probe <break/>Assay ID: <break/>CTAAADA</td><td valign="top">Custom RT-qPCR primer <break/>designed using the Thermofisher <break/>Scientific design tool at <break/><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/order/custom-">https://www.thermofisher.com/order/custom-</ext-link> <break/>genomic-products/tools/small-rna to <break/>specifically detect small RNAs from cluster 21 <break/>of CD95L <break/>(5&#8217;- TCAACGTATCTGAGCTCTCTC-3&#8217;)</td></tr><tr><td valign="top">Sequence based <break/>reagent (human)</td><td valign="top">z30 primer</td><td valign="top">Thermofisher Scientific</td><td valign="top">ThermoFisher <break/>Scientific #4427975</td><td valign="top">RT-qPCR for small RNA; <break/>control probe</td></tr><tr><td valign="top">Peptide, <break/>recombinant <break/>protein</td><td valign="top">Flag-GST-T6B <break/>peptide</td><td valign="top">PMID: 26351695</td><td valign="top">NA</td><td valign="top">Peptide derived from <break/>GW182/TNRC6B used to <break/>pull down AGO1 to 4</td></tr><tr><td valign="top">Commercial <break/>assay or kit</td><td valign="top">anti-Flag M2 <break/>magnetic beads</td><td valign="top">Sigma-Aldrich</td><td valign="top">Sigma-Aldrich #M8823</td><td valign="top"/></tr></tbody></table></table-wrap>